Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 14.82 Million USD | -3.29% |
| 2021 | 15.33 Million USD | -30.29% |
| 2020 | 21.99 Million USD | -56.35% |
| 2019 | 50.38 Million USD | 135.29% |
| 2018 | 21.41 Million USD | 21.59% |
| 2017 | 17.61 Million USD | 37.25% |
| 2016 | 12.83 Million USD | 302.07% |
| 2015 | 3.19 Million USD | 446.52% |
| 2014 | -921 Thousand USD | -22713.97% |
| 2013 | -4037.00 USD | 99.89% |
| 2012 | -3.53 Million USD | 54.8% |
| 2011 | -7.82 Million USD | -3.23% |
| 2010 | -7.57 Million USD | -3.8% |
| 2009 | -7.29 Million USD | 41.57% |
| 2008 | -12.49 Million USD | 35.14% |
| 2007 | -19.25 Million USD | 25.26% |
| 2006 | -25.76 Million USD | -87.28% |
| 2005 | -13.75 Million USD | -98.79% |
| 2004 | -6.92 Million USD | -57.26% |
| 2003 | -4.4 Million USD | -805.56% |
| 2002 | -486 Thousand USD | 93.23% |
| 2001 | -7.17 Million USD | 18.11% |
| 2000 | -8.76 Million USD | 11.99% |
| 1999 | -9.95 Million USD | 42.76% |
| 1998 | -17.4 Million USD | 31.23% |
| 1997 | -25.3 Million USD | 14.81% |
| 1996 | -29.7 Million USD | -42.11% |
| 1995 | -20.9 Million USD | -302.91% |
| 1994 | 10.3 Million USD | 139.53% |
| 1993 | 4.3 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 11.72 Million USD | -13.63% |
| 2023 Q1 | 13.58 Million USD | -8.43% |
| 2023 Q3 | 12.11 Million USD | 3.27% |
| 2022 Q2 | 15.04 Million USD | -2.39% |
| 2022 Q1 | 15.4 Million USD | 0.49% |
| 2022 Q4 | 14.82 Million USD | -2.55% |
| 2022 Q3 | 15.21 Million USD | 1.18% |
| 2022 FY | 14.82 Million USD | -3.29% |
| 2021 Q2 | 23.47 Million USD | 1.33% |
| 2021 Q4 | 15.33 Million USD | -33.72% |
| 2021 FY | 15.33 Million USD | -30.29% |
| 2021 Q1 | 23.16 Million USD | 5.31% |
| 2021 Q3 | 23.13 Million USD | -1.43% |
| 2020 Q2 | 35.78 Million USD | -33.7% |
| 2020 Q1 | 53.96 Million USD | 7.1% |
| 2020 Q3 | 21.67 Million USD | -39.42% |
| 2020 Q4 | 21.99 Million USD | 1.47% |
| 2020 FY | 21.99 Million USD | -56.35% |
| 2019 Q2 | 33.25 Million USD | 23.03% |
| 2019 Q1 | 27.03 Million USD | 26.22% |
| 2019 FY | 50.38 Million USD | 135.29% |
| 2019 Q4 | 50.38 Million USD | 4.75% |
| 2019 Q3 | 48.1 Million USD | 44.65% |
| 2018 Q4 | 21.41 Million USD | 8.99% |
| 2018 FY | 21.41 Million USD | 21.59% |
| 2018 Q2 | 19.78 Million USD | 16.75% |
| 2018 Q1 | 16.94 Million USD | -3.78% |
| 2018 Q3 | 19.64 Million USD | -0.7% |
| 2017 Q2 | 15.05 Million USD | 62.5% |
| 2017 Q1 | 9.26 Million USD | -27.82% |
| 2017 FY | 17.61 Million USD | 37.25% |
| 2017 Q4 | 17.61 Million USD | 26.27% |
| 2017 Q3 | 13.94 Million USD | -7.33% |
| 2016 Q3 | 12.12 Million USD | -24.89% |
| 2016 Q1 | 10.83 Million USD | 480.16% |
| 2016 Q2 | 16.13 Million USD | 48.92% |
| 2016 FY | 12.83 Million USD | 302.07% |
| 2016 Q4 | 12.83 Million USD | 5.87% |
| 2015 Q3 | -4.66 Million USD | 15.82% |
| 2015 FY | 3.19 Million USD | 446.52% |
| 2015 Q2 | -5.54 Million USD | 20.68% |
| 2015 Q1 | -6.98 Million USD | -2204.82% |
| 2015 Q4 | 1.86 Million USD | 140.03% |
| 2014 Q4 | 332 Thousand USD | 153.81% |
| 2014 FY | -921 Thousand USD | -22713.97% |
| 2014 Q1 | -921 Thousand USD | 50.43% |
| 2014 Q3 | -617 Thousand USD | 60.37% |
| 2014 Q2 | -1.55 Million USD | -69.06% |
| 2013 Q4 | -1.85 Million USD | 18.65% |
| 2013 Q3 | -2.28 Million USD | 21.75% |
| 2013 Q2 | -2.91 Million USD | 17.43% |
| 2013 Q1 | -3.53 Million USD | 22.7% |
| 2013 FY | -4037.00 USD | 99.89% |
| 2012 Q2 | -7.19 Million USD | 8.04% |
| 2012 Q3 | -5.71 Million USD | 20.5% |
| 2012 Q4 | -4.57 Million USD | 20.01% |
| 2012 FY | -3.53 Million USD | 54.8% |
| 2012 Q1 | -7.82 Million USD | 5.37% |
| 2011 Q2 | -7.02 Million USD | 7.23% |
| 2011 FY | -7.82 Million USD | -3.23% |
| 2011 Q4 | -8.26 Million USD | -27.97% |
| 2011 Q3 | -6.45 Million USD | 8.1% |
| 2011 Q1 | -7.57 Million USD | 3.99% |
| 2010 FY | -7.57 Million USD | -3.8% |
| 2010 Q2 | -6.2 Million USD | 14.98% |
| 2010 Q1 | -7.29 Million USD | 6.82% |
| 2010 Q4 | -7.89 Million USD | -80.43% |
| 2010 Q3 | -4.37 Million USD | 29.52% |
| 2009 Q1 | -12.49 Million USD | 1.8% |
| 2009 FY | -7.29 Million USD | 41.57% |
| 2009 Q2 | -10.45 Million USD | 16.32% |
| 2009 Q3 | -8.61 Million USD | 17.57% |
| 2009 Q4 | -7.83 Million USD | 9.1% |
| 2008 Q4 | -12.72 Million USD | 9.21% |
| 2008 Q2 | -18.17 Million USD | 5.63% |
| 2008 Q1 | -19.25 Million USD | 2.72% |
| 2008 Q3 | -14.01 Million USD | 22.9% |
| 2008 FY | -12.49 Million USD | 35.14% |
| 2007 FY | -19.25 Million USD | 25.26% |
| 2007 Q1 | -25.76 Million USD | 12.55% |
| 2007 Q2 | -23.34 Million USD | 9.38% |
| 2007 Q3 | -20.34 Million USD | 12.85% |
| 2007 Q4 | -19.79 Million USD | 2.71% |
| 2006 Q3 | -10.44 Million USD | 16.7% |
| 2006 Q1 | -13.75 Million USD | 8.74% |
| 2006 FY | -25.76 Million USD | -87.28% |
| 2006 Q2 | -12.53 Million USD | 8.9% |
| 2006 Q4 | -29.46 Million USD | -182.23% |
| 2005 Q2 | -3.1 Million USD | 55.18% |
| 2005 Q4 | -15.07 Million USD | 16.93% |
| 2005 Q1 | -6.92 Million USD | -64.55% |
| 2005 FY | -13.75 Million USD | -98.79% |
| 2005 Q3 | -18.14 Million USD | -485.04% |
| 2004 Q4 | -4.2 Million USD | -28.78% |
| 2004 Q2 | -4.35 Million USD | 1.11% |
| 2004 FY | -6.92 Million USD | -57.26% |
| 2004 Q1 | -4.4 Million USD | 8.26% |
| 2004 Q3 | -3.26 Million USD | 24.95% |
| 2003 Q1 | -486 Thousand USD | 83.14% |
| 2003 Q3 | -6.92 Million USD | -1478.36% |
| 2003 FY | -4.4 Million USD | -805.56% |
| 2003 Q4 | -4.79 Million USD | 30.77% |
| 2003 Q2 | -439 Thousand USD | 9.67% |
| 2002 Q4 | -2.88 Million USD | -2.6% |
| 2002 Q1 | -7.17 Million USD | -4.21% |
| 2002 Q2 | -5.17 Million USD | 27.85% |
| 2002 FY | -486 Thousand USD | 93.23% |
| 2002 Q3 | -2.8 Million USD | 45.76% |
| 2001 Q4 | -6.88 Million USD | -9.21% |
| 2001 Q1 | -8.76 Million USD | 34.38% |
| 2001 Q2 | -3.61 Million USD | 58.78% |
| 2001 FY | -7.17 Million USD | 18.11% |
| 2001 Q3 | -6.3 Million USD | -74.56% |
| 2000 FY | -8.76 Million USD | 11.99% |
| 2000 Q3 | -5.7 Million USD | 32.88% |
| 2000 Q4 | -13.35 Million USD | -134.1% |
| 2000 Q2 | -8.5 Million USD | 14.64% |
| 2000 Q1 | -9.95 Million USD | -231.97% |
| 1999 FY | -9.95 Million USD | 42.76% |
| 1999 Q2 | -9.9 Million USD | 43.1% |
| 1999 Q3 | -6.6 Million USD | 33.33% |
| 1999 Q4 | -3 Million USD | 54.55% |
| 1999 Q1 | -17.4 Million USD | 12.56% |
| 1998 Q2 | -22.4 Million USD | 11.46% |
| 1998 Q4 | -19.9 Million USD | -1.02% |
| 1998 FY | -17.4 Million USD | 31.23% |
| 1998 Q1 | -25.3 Million USD | -8.12% |
| 1998 Q3 | -19.7 Million USD | 12.05% |
| 1997 FY | -25.3 Million USD | 14.81% |
| 1997 Q4 | -23.4 Million USD | 6.77% |
| 1997 Q1 | -29.7 Million USD | -0.34% |
| 1997 Q3 | -25.1 Million USD | 2.71% |
| 1997 Q2 | -25.8 Million USD | 13.13% |
| 1996 Q3 | -24.8 Million USD | -58.97% |
| 1996 Q4 | -29.6 Million USD | -19.35% |
| 1996 FY | -29.7 Million USD | -42.11% |
| 1996 Q1 | -20.9 Million USD | 0.0% |
| 1996 Q2 | -15.6 Million USD | 25.36% |
| 1995 Q4 | -20.9 Million USD | -241.69% |
| 1995 FY | -20.9 Million USD | -302.91% |
| 1995 Q3 | 14.75 Million USD | 20.9% |
| 1995 Q1 | 10.3 Million USD | 0.0% |
| 1995 Q2 | 12.2 Million USD | 18.45% |
| 1994 FY | 10.3 Million USD | 139.53% |
| 1993 FY | 4.3 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -572.252% |
| Arrayit Corporation | 1.05 Million USD | -1304.903% |
| Atlantic International Corp. | 236.49 Thousand USD | -6170.667% |
| Biocept, Inc. | -788 Thousand USD | 1981.964% |
| Bioqual, Inc. | -12 Million USD | 223.509% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -65117.806% |
| DermTech, Inc. | 17.65 Million USD | 15.992% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 102.59% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 301.031% |
| iMD Companies, Inc. | 1.11 Million USD | -1228.944% |
| IDenta Corp. | 524.85 Thousand USD | -2725.535% |
| Interpace Biosciences, Inc. | 7.69 Million USD | -92.746% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 55123.29% |
| InVitro International | -313.14 Thousand USD | 4835.831% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -847.043% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 2080026.648% |
| Medical Imaging Corp. | 3.79 Million USD | -291.193% |
| NovelStem International Corp. | 3.52 Million USD | -321.12% |
| Optigenex Inc. | 8.93 Million USD | -65.994% |
| PharmChem, Inc. | -1.49 Million USD | 1092.355% |
| Proteome Sciences plc | 14.57 Million USD | -1.761% |
| Response Genetics, Inc | -13.08 Million USD | 213.326% |
| RushNet, Inc. | 4.8 Million USD | -208.901% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -10837.375% |
| Stella Diagnostics Inc. | 6.19 Million USD | -139.46% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -731.085% |
| Todos Medical Ltd. | 38.31 Million USD | 61.294% |